Biolevate
Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing
Biolevate has raised €36M across 2 funding rounds from 5 investors, most recently a Series A round in Sep 2026. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.biolevate.com ↗
Total raised
€36M
€36,000,000
Funding rounds
2
Investors
5
distinct backers
Active since
2024-11
latest 2026-09
Funding by year
EUR raised per year · 2026 YTDBiolevate — funding by year — interactive chart.
Data table
| Biolevate — funding by year | |
|---|---|
| 2024 | €6.0M |
| 2026 | €30M |
Signals
High confidenceRaise-next likelihood19
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-22 | Series A | €30M | EQT Ventures,MSD Global Health Innovation Fund (MGHIF),Orange Ventures,RAISE France,STATION F | View deal → |
| 2024-11-26 | Seed | €6.0M | EQT Ventures | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData